Lexaria Bioscience Corp. (LEXX)
0.6109
+0.01
(+1.41%)
USD |
NASDAQ |
May 14, 16:00
Lexaria Bioscience Shareholders Equity (Quarterly) : 6.602M for Feb. 28, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -30.15M |
| InMed Pharmaceuticals, Inc. | 6.892M |
| Target Group, Inc. (Canada) | -8.063M |
| Tilray Brands, Inc. | 1.557B |
| NervGen Pharma Corp. | 2.536M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.487M |
| Total Liabilities (Quarterly) | 0.277M |
| Debt to Equity Ratio | 0.0143 |
| Current Ratio | 26.88 |
| Net Debt Paydown Yield | 0.04% |